Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India And China Not Yet Major Sites For FDA-Regulated Trials, Parexel Finds

Executive Summary

While India now ranks among the top 10 countries conducting FDA-regulated clinical trials, it has yet to see a major influx of trial work

You may also be interested in...



Clinical Trial Outsourcing: Germany Is #2; India’s Investigator Ranks Jump 30%

Germany ranks just behind the United States as the go-to place for FDA-regulated clinical trials

Clinical Trial Outsourcing: Germany Is #2; India’s Investigator Ranks Jump 30%

Germany ranks just behind the United States as the go-to place for FDA-regulated clinical trials

Ex-FDA Commissioner Crawford Calls For New Global Harmonization Effort

CAMBRIDGE, MA-A new global organization should be established to promote the harmonization of regulatory requirements between countries, Lester Crawford proposed Aug. 22 at the FDA Regulatory and Compliance Symposium

Related Content

UsernamePublicRestriction

Register

PS048428

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel